COVID-19 Epidemiology and Infection Control

Since its emergence in late 2019, SARS-CoV-2 has demonstrated a capacity for rapid global dissemination, driven by a combination of presymptomatic transmission, high population mobility and evolving viral variants. Epidemiological investigations have characterised case clusters in diverse settings—from care homes and congregate living to international travel hubs—revealing heterogeneity in attack rates, clinical severity and risk factors such as age, comorbidities and social deprivation. Infection control has relied on a layered strategy that integrates rapid molecular diagnostics, robust contact tracing, non-pharmaceutical interventions (NPIs) including universal masking and physical distancing, environmental measures such as improved ventilation and directly observed environmental disinfection, and, crucially, vaccination. The interplay between emerging variants and waning immunity necessitates continuous surveillance of serological markers and viral genomics. Practical applications range from refining outbreak response protocols in healthcare and community settings to optimising vaccine deployment to vulnerable subgroups, underscoring the global importance of adaptive, evidence-based control measures.

Research from Nature Portfolio

Recent seroepidemiological analysis reveals that prior to the major Omicron BA.2 wave, overall neutralising antibody prevalence against ancestral and variant strains was markedly low in older age groups despite high reported vaccination uptake. Age-stratified seroprevalence correlated imperfectly with immunisation rates, indicating suboptimal vaccine-induced protection in the most vulnerable cohorts. This deficit in herd immunity was associated with an exceptionally high case-fatality rate among individuals aged 80 years and above during the early 2022 BA.2 surge. The study highlights the critical need for ongoing sero-surveillance to guide booster campaigns and to monitor population-level protection against emerging SARS-CoV-2 variants.

COVID-19 Epidemiology and Infection Control publication trend

The graph below shows the total number of articles in covid-19 epidemiology and infection control across all publications each year (not limited to Nature Index journals).

Technical terms

Epidemiology: The study of distribution, patterns and determinants of health and disease conditions in defined populations.

Seroprevalence: The proportion of individuals in a population who have detectable antibodies against an infectious agent at a given time.

Attack rate: The proportion of at-risk individuals who become infected during a specified period following exposure to a pathogen.

Non-pharmaceutical interventions (NPIs): Public health measures such as masking, distancing and hygiene practices that reduce transmission in the absence of medical countermeasures.

Nosocomial transmission: Spread of an infectious agent within a healthcare setting, affecting patients or staff.

Herd immunity: Indirect protection from infection conferred when a sufficient proportion of a population is immune, reducing pathogen transmission.

References

1. COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19–Associated Hospitalization Among Residents in Nursing Homes — National Healthcare Safety Network, United States, October 2023–February 2024. MMWR Morbidity and Mortality Weekly Report (2024).
2. Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong. Nature Communications (2022).
3. Evolution and Control of COVID-19 Epidemic in Hong Kong. Viruses (2022).
4. Infection control challenges in setting up community isolation and treatment facilities for patients with coronavirus disease 2019 (COVID-19): Implementation of directly observed environmental disinfection. Infection Control and Hospital Epidemiology (2020).
5. Travel in the Time of COVID: A Review of International Travel Health in a Global Pandemic. Current Infectious Disease Reports (2022).